Inhibitory effects of Rap1GAP overexpression on proliferation and migration of endothelial cells via ERK and Akt pathways

Abstract

Rap1 is expressed in human umbilical vein endothelial cells (HUVECs). Rap1-GTPase activating protein (Rap1GAP), with its specific target, Rap1, has been shown to be important in the regulation of many physiological and certain pathological processes. In this study, we investigated the effect of Rap1GAP expression on endothelial cell function, or, more specifically, proliferation and migration of endothelial cells. HUVECs were transfected with pcDNA3.1 (empty vector), pcDNA3.1 containing Flag-tagged-Rap1GAP or Myc-tagged-Rap1N17. The proliferation, migration and tube formation were examined and compared among the 3 groups. Expression of Rap1, Rap1GAP, extracellular signal-regulated kinase (ERK), phospho-ERK, Akt, phosphor-Akt was detected by Western blotting. The results showed that the proliferation, migration and tube formation were significantly reduced in Rap1GAP- and Rap1N17-transfected HUVECs as compared with empty vector-transfected control. These changes were coincident with increased expression of Rap1GAP and decreased expression of activated Rap1, phospho-ERK and -Akt. After treatment of Rap1GAP-transfected HUVECs with a stimulator of Rap1 guanine-nucleotide-exchange factor (Rap1GEF) 8CPT-2′OMe-cAMP, it was found that Rap1 activity was decreased as compared with empty vector-transfected control. Pretreatment of HUVECs with an ERK inhibitor PD98059 or a PI3K inhibitor LY294002 prior to stimulation not only blocked 8CPT-2′OMe-cAMP-induced phosphorylation of ERK and Akt, but also significantly reduced cell proliferation and migration. Finally, we examined the effect of vascular endothelial growth factor (VEGF) on HUVECs overexpressing Rap1GAP. VEGF-stimulated Rap1 activity, phosphorylation of ERK and Akt, cyclin D1 expression and cell proliferation were repressed in HUVECs overexpressing Rap1GAP as compared to empty vector-transfected control. Taken together, our findings demonstrate that Rap1GAP/Rap1 and their downstream effectors regulate proliferation and migration of HUVECs via ERK and Akt pathways.

Keywords

Rap1GAP protein / Rap1 / endothelial cells / proliferation / migration

References

[1] MilkiewiczM., IspanovicE., DoyleJ.L., et al.. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol, 2006, 38(3): 333-357

[2] CarmelietP.. Angiogenesis in life, disease and medicine. Nature, 2005, 438(7070): 932-936

[3] TakaiY., SasakiT., MatozakiT.. Small GTP-binding proteins. Physiol Rev, 2001, 81(1): 153-208

[4] McLeodS.J., ShumA.J., LeeR.L., et al.. The Rap GTPases regulate integrin-mediated adhesion, cell spreading, actin polymerization, and Pyk2 tyrosine phosphorylation in B lymphocytes. J Biol Chem, 2004, 279(13): 12009-12019

[5] SinghL., GaoQ., KumarA., et al.. The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins. J Virol, 2003, 77(2): 1614-1620

[6] GaoQ., KumarA., SinghL., et al.. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res, 2002, 62(11): 3315-3321

[7] KurachiH., WadaY., TsukamotoN., et al.. Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product. J Biol Chem, 1997, 272(44): 28081-28088

[8] IshidaD., KometaniK., YangH., et al.. Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice. Cancer Cell, 2003, 4(1): 55-65

[9] TsygankovaO.M., FeshchenkoE., KleinP.S., et al.. Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3beta elicit opposing effects on Rap1GAP stability. J Biol Chem, 2004, 279(7): 5501-5507

[10] TsygankovaO.M., PrendergastG.V., PuttaswamyK., et al.. Downregulation of Rap1GAP contributes to Ras transformation. Mol Cell Biol, 2007, 27(19): 6647-6658

[11] NelloreA., PazianaK., MaC., et al.. Loss of Rap1GAP in papillary thyroid cancer. J Clin Endocrinol Metab, 2009, 94(3): 1026-1032

[12] ZhangL., ChenweiL., MahmoodR., et al.. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Res, 2006, 66(2): 898-906

[13] ZhengH., GaoL., FengY., et al.. Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. Cancer Res, 2009, 69(2): 449-457

[14] ZuoH., GandhiM., EdreiraM.N., et al.. Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors. Cancer Res, 2010, 70(4): 1389-1397

[15] TsygankovaO.M., MaC., TangW., et al.. Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol Cell Biol, 2010, 30(13): 3262-3274

[16] RangarajanS., EnserinkJ.M., KuiperijH.B., et al.. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β₂-adrenergic receptor. J Cell Biol, 2003, 160(4): 487-493

[17] de BruynK.M., ZwartkruisF.J., de RooijJ., et al.. The small GTPase Rap1 is activated by turbulence and is involved in integrin αIIbβ3-mediated cell adhesion in human megakaryocytes. J Biol Chem, 2003, 278(25): 22412-22417

[18] CarmonaG., GöttigS., OrlandiA., et al.. Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis. Blood, 2009, 113(2): 488-497

[19] FukuharaS., SakuraiA., SanoH., et al.. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol, 2005, 25(1): 136-146

[20] YanJ., LiF., IngramD.A., et al.. Rap1a is a key regulator of FGF2-induced angiogenesis and together with Rap1b controls human endothelial cell functions. Mol Cell Biol, 2008, 28(18): 5803-5810

[21] Chrzanowska-WodnickaM., KrausA.E., GaleD., et al.. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood, 2008, 111(5): 2647-2656

[22] NagashimaK., EndoA., OgitaH., et al.. Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol Biol Cell, 2002, 13(12): 4231-4242

[23] RobertsD.M., AndersonA.L., HidakaM., et al.. A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters. Mol Cell Biol, 2004, 24(24): 10515-10528

[24] FujitaH., FukuharaS., SakuraiA., et al.. Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes. J Biol Chem, 2005, 280(6): 5022-5031

[25] WittchenE.S., WorthylakeR.A., KellyP., et al.. Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem, 2005, 280(12): 11675-11682

[26] JaffeE.A., NachmanR.L., BeckerC.G., et al.. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest, 1973, 52(11): 2745-2756

[27] FangY., OlahM.E.. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J Pharmacol Exp Ther, 2007, 322(3): 1189-1200

[28] MisraU.K., KaczowkaS., PizzoS.V.. The cAMP-activated GTP exchange factor, Epac1 upregulates plasma membrane and nuclear Akt kinase activities in 8-CPT-2-O-Me-cAMP-stimulated macrophages: gene silencing of the cAMP-activated GTP exchange Epac1 prevents 8-CPT-2-O-Me-cAMP activation of Akt activity in macrophages. Cell Signal, 2008, 20(8): 1459-1470

[29] MitraR.S., GotoM., LeeJ.S., et al.. Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res, 2008, 68(10): 3959-3969

[30] HoS.M., LauK.M., MokS.C., et al.. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene, 2003, 22(27): 4243-4256

[31] DoebeleR.C., Schulze-HoepfnerF.T., HongJ., et al.. A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombo-spondin to control angiogenesis. Blood, 2009, 114(20): 4592-4600

[32] HatanoN., MoriY., Oh-horaM., et al.. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells, 2003, 8(11): 847-856

[33] WangL., LiuF., AdamoM.L.. Cyclic AMP inhibits extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1. J Biol Chem, 2001, 276(40): 37242-37249

[34] BraderS., EcclesS.A.. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumor, 2004, 90(1): 2-8

[35] SomanathP.R., RazorenovaO.V., ChenJ., et al.. Akt1 in endothelial cell and angiogenesis. Cell Cycle, 2006, 5(5): 512-518

[36] SomanathP.R., KandelE.S., HayN., et al.. Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J Biol Chem, 2007, 282(31): 22964-22976

[37] FavotL., KeravisT., LugnierC.. Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4. Thromb Haemost, 2004, 92(3): 634-645

[38] WeberJ.D., RabenD.M., PhillipsP.J., et al.. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J, 1997, 326(pt1): 61-68

[39] HanaiJ., DhanabalM., KarumanchiS.A., et al.. Endostatin causes G1 arrest of endothelial cells through inhibition of Cyclin D1. J Biol Chem, 2002, 277(19): 16464-16469

[40] ZhangZ., MitraR.S., HensonB.S., et al.. Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am J Pathol, 2006, 168(2): 585-596